RefleXion, Telix partner on high-risk cancer treatments
July 8, 2020 -- Radiation therapy equipment developer RefleXion Medical and radiopharmaceutical company Telix Pharmaceuticals are investigating the clinical utility of combining their technologies for improving treatments for high-risk prostate and aggressive kidney cancers.
July 8, 2020 -- Radiation therapy equipment developer RefleXion Medical and radiopharmaceutical company Telix Pharmaceuticals are investigating the clinical utility of combining their technologies for improving treatments for high-risk prostate and aggressive kidney cancers.
Brainlab buys medical video game developer
June 29, 2020 -- Image-guided therapy firm Brainlab has purchased Level Ex, a company that develops medical video games to hone physicians' skills.
June 29, 2020 -- Image-guided therapy firm Brainlab has purchased Level Ex, a company that develops medical video games to hone physicians' skills.
ViewRay highlights results from prostate cancer study
June 25, 2020 -- Image-guided radiation therapy vendor ViewRay is highlighting the results of a clinical study on the use of its MR-guided radiation therapy technology for treating men with prostate cancer.
June 25, 2020 -- Image-guided radiation therapy vendor ViewRay is highlighting the results of a clinical study on the use of its MR-guided radiation therapy technology for treating men with prostate cancer.
FDA debuts website for patient-reported cancer outcomes
June 24, 2020 -- The U.S. Food and Drug Administration (FDA) has unveiled Project Patient Voice, a new pilot program for communicating patient-reported outcomes from cancer clinical trials.
June 24, 2020 -- The U.S. Food and Drug Administration (FDA) has unveiled Project Patient Voice, a new pilot program for communicating patient-reported outcomes from cancer clinical trials.
Lantheus completes Progenics purchase
June 22, 2020 -- Lantheus Holdings, parent company of Lantheus Medical Imaging, has completed its purchase of oncology drug developer Progenics Pharmaceuticals.
June 22, 2020 -- Lantheus Holdings, parent company of Lantheus Medical Imaging, has completed its purchase of oncology drug developer Progenics Pharmaceuticals.
New radioisotope therapy treats pediatric neuroblastoma
June 22, 2020 -- Japanese researchers have discovered a new radioisotope therapy for children with neuroblastoma.
June 22, 2020 -- Japanese researchers have discovered a new radioisotope therapy for children with neuroblastoma.
Accuray launches CyberKnife S7 system
June 17, 2020 -- Radiation oncology firm Accuray has launched CyberKnife S7 system, the latest generation of the company's CyberKnife radiation therapy platform.
June 17, 2020 -- Radiation oncology firm Accuray has launched CyberKnife S7 system, the latest generation of the company's CyberKnife radiation therapy platform.
NorthStar, Monopar team up to create COVID-19 therapies
June 16, 2020 -- NorthStar Medical Radioisotopes and biopharmaceutical firm Monopar Therapeutics are collaborating to develop potential radioimmune therapeutics (RITs) to treat patients with severe COVID-19.
June 16, 2020 -- NorthStar Medical Radioisotopes and biopharmaceutical firm Monopar Therapeutics are collaborating to develop potential radioimmune therapeutics (RITs) to treat patients with severe COVID-19.
RaySearch unveils new RayStation release
June 16, 2020 -- Radiation therapy software developer RaySearch Laboratories has introduced the latest release of its RayStation treatment planning software.
June 16, 2020 -- Radiation therapy software developer RaySearch Laboratories has introduced the latest release of its RayStation treatment planning software.
Philips teams up with MD Anderson in oncology
June 16, 2020 -- Royal Philips, the parent company of Philips Healthcare, said it has formed a partnership with the University of Texas MD Anderson Cancer Center to better personalize oncology treatment for patients.
June 16, 2020 -- Royal Philips, the parent company of Philips Healthcare, said it has formed a partnership with the University of Texas MD Anderson Cancer Center to better personalize oncology treatment for patients.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT